CSS LLC/IL - ACORDA THERAPEUTICS INC ownership

ACORDA THERAPEUTICS INC's ticker is and the CUSIP is 00484MAA4. A total of 42 filers reported holding ACORDA THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
CSS LLC/IL ownership history of ACORDA THERAPEUTICS INC
ValueSharesWeighting
Q3 2019$3,564,000
-51.1%
4,547,000
-47.2%
0.23%
-45.3%
Q2 2019$7,295,000
+43.7%
8,607,000
+50.1%
0.42%
+37.4%
Q1 2019$5,078,000
-16.4%
5,735,000
-20.7%
0.30%
-25.1%
Q4 2018$6,076,000
+823.4%
7,235,000
+832.3%
0.41%
+1353.6%
Q3 2018$658,000
-13.0%
776,0000.0%0.03%
-20.0%
Q2 2018$756,000
-78.2%
776,000
-79.4%
0.04%
-79.7%
Q1 2018$3,461,000
-47.3%
3,776,000
-51.1%
0.17%
-46.7%
Q4 2017$6,570,000
+95.6%
7,716,000
+107.6%
0.32%
+97.0%
Q3 2017$3,359,000
+6.3%
3,716,0000.0%0.16%
+7.2%
Q2 2017$3,159,000
-12.2%
3,716,000
-11.9%
0.15%
-29.2%
Q1 2017$3,600,000
+213.9%
4,216,000
+181.1%
0.22%
+242.9%
Q4 2016$1,147,000
-75.0%
1,500,000
-62.3%
0.06%
-76.8%
Q4 2015$4,586,000
+402.9%
3,981,000
+298.1%
0.27%
+403.7%
Q3 2015$912,000
-81.9%
1,000,000
-80.0%
0.05%
-77.1%
Q2 2015$5,052,000
-16.8%
5,000,000
-15.7%
0.24%
-23.4%
Q1 2015$6,069,000
+5.6%
5,934,000
+18.7%
0.31%
+7.7%
Q4 2014$5,749,000
+178.4%
5,000,000
+150.0%
0.29%
+186.0%
Q3 2014$2,065,0002,000,0000.10%
Other shareholders
ACORDA THERAPEUTICS INC shareholders Q2 2017
NameSharesValueWeighting ↓
SYMPHONY ASSET MANAGEMENT LLC 23,872,000$18,748,0004.04%
PFM Health Sciences, LP 49,764,825$39,319,0001.16%
Partner Investment Management, L.P. 659,175$521,0000.89%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 40,000,000$31,402,000,0000.87%
Bruce & Co., Inc. 6,000,000$4,200,0000.87%
CANYON CAPITAL ADVISORS LLC 36,500,000$28,747,0000.62%
PenderFund Capital Management Ltd. 2,000,000$1,571,0000.53%
Shaolin Capital Management LLC 4,000,000$3,136,0000.48%
Castle Creek Arbitrage, LLC 2,310,000$1,815,0000.46%
TENOR CAPITAL MANAGEMENT Co., L.P. 5,500,000$4,368,0000.27%
View complete list of ACORDA THERAPEUTICS INC shareholders